BIOMAT Database Logo BIOMAT Database Logo

[Lysosomal enzymes and their natural inhibitors in the serum and bronchoalveolar lavage fluid in chronic bronchitis and pneumonia]. 1988

T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska

UI MeSH Term Description Entries
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females

Related Publications

T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska
Interaction of lysosomal enzymes and their natural inhibitors in bronchoalveolar lavage fluid and serum in atopic bronchial asthma.
January 1987, Archivum immunologiae et therapiae experimentalis,
T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska
Analysis of proteolytic enzymes and their natural inhibitors in serum and bronchial lavage fluid in atopic bronchial asthma, chronic bronchitis and pneumonia.
January 1985, Allergie und Immunologie,
T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska
[Proteolytic activities in bronchoalveolar lavage fluid in pneumonia and chronic bronchitis].
February 1990, Pneumologie (Stuttgart, Germany),
T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska
[IGA concentration in serum, sputum and bronchoalveolar lavage in chronic bronchitis].
October 1987, Deutsche medizinische Wochenschrift (1946),
T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska
[Elastase and acid phosphatase activity in bronchoalveolar lavage fluid during chronic bronchitis].
February 1990, Biulleten' eksperimental'noi biologii i meditsiny,
T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska
[Biogenic amines and acetylcholine in the bronchoalveolar lavage fluid of patients with chronic bronchitis].
December 1988, Klinicheskaia meditsina,
T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska
Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid.
June 2001, Respiratory medicine,
T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska
Cytology of bronchoalveolar lavage fluid in bacterial pneumonia.
June 1990, Chest,
T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska
Bronchoalveolar lavage fluid and blood natural killer and natural killer T-like cells in cryptogenic organizing pneumonia.
July 2014, Respirology (Carlton, Vic.),
T Płusa, and E Zaraś, and A Raczka, and H Tchórzewski, and J Kruszewski, and A Frank-Piskorska
Cotinine levels in serum and bronchoalveolar lavage fluid.
September 2010, The Southeast Asian journal of tropical medicine and public health,
Copied contents to your clipboard!